Teva Pharmaceutical Industries Limited Share Price TEL AVIV STOCK EXCHANGE
Equities
IL0006290147
Pharmaceuticals
Sales 2024 * | 15.92B 5,917B 1,271B | Sales 2025 * | 16.49B 6,129B 1,317B | Capitalization | 18.41B 6,841B 1,470B |
---|---|---|---|---|---|
Net income 2024 * | 820M 305B 65.49B | Net income 2025 * | 1.39B 516B 111B | EV / Sales 2024 * | 2.09 x |
Net Debt 2024 * | 14.93B 5,548B 1,192B | Net Debt 2025 * | 12.41B 4,612B 991B | EV / Sales 2025 * | 1.87 x |
P/E ratio 2024 * |
17.3
x | P/E ratio 2025 * |
12
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.71% |
Latest transcript on Teva Pharmaceutical Industries Limited
Managers | Title | Age | Since |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 31/12/22 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 21/12/19 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 31/08/15 |
Janet Vergis
BRD | Director/Board Member | 59 | 08/06/20 |
Sol Barer
CHM | Chairman | 76 | 31/12/14 |
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |